Locations:
Search IconSearch
January 30, 2026/Cancer/Radiation Oncology

Patient Case Study: Radiation Therapy Used to Treat Dupuytren's Disease

Radiation therapy helped shrink hand nodules and improve functionality

Hands after RT

A man in his 70s is among a group of patients who were successfully treated with radiation therapy for the benign condition Dupuytren’s disease. The brief course of treatment reduced the size of nodules on his hands and helped him continue daily activities.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Background

The patient, an avid guitar player in a rock band, noticed a nodule developing on the palm of his left hand, and found a similar growth on his right hand several weeks later. At first he thought it might be due to new handgrips he was using on his motorcycle, but when he began experiencing discomfort, he sought medical advice. He reported what felt like momentary electric shocks coming from the affected area.

As an active person, he was concerned that the issue could affect his ability to perform. He saw an orthopedic surgeon, who diagnosed him with Dupuytren's disease, a disorder that causes the tissue under the skin on extremities to thicken and tighten. If left untreated, Dupuytren’s disease can lead to permanent contracture of the hands and fingers.

Treatment options

The orthopedic surgeon offered three treatment options:

  • Surgery, which would require considerable downtime
  • Injections of an enzyme, which would cost several thousands of dollars and wasn’t covered by insurance
  • Living with the condition, which would likely progress over time

The patient was keen to find another way to address the issue, and when he heard about the possibility of radiation therapy to treat it, he sought a consultation with Rahul Tendulkar, MD, who treats a number of benign and cancerous conditions as part of Cleveland Clinic’s Radiation Oncology team.

“The patient was the ideal candidate for radiation therapy,” explains Dr. Tendulkar. “This treatment is best at the early stage of Dupuytren’s disease when someone has a nodule but their fingers aren't contracted or there is contracture that’s no more than 10 degrees.”

Advertisement

Dupuytren's disease is caused by fibroblasts (connective tissue cells) that go awry and grow abnormally. Fibroblast cells tend to be sensitive to the effects of radiation. Using a moderately low dose of radiation therapy may help to keep these cells from proliferating.

In this case, radiation was a preventative strategy to keep the nodules from progressing so that the patient didn’t lose function in his hands. Treatment for the patient involved electron beam therapy directed at the affected area and a small margin around it. The patient received five treatments over the course of a week, and then another five treatments roughly two months later, directed on each hand.

Like most patients receiving this type of radiation, he tolerated treatment fine with no noticeable side effects.

Outcome

“In roughly two-thirds of cases, patients experience a positive benefit from radiation in terms of functional improvement, reduction in pain or prevention of progression to a more advanced stage,” says Dr. Tendulkar. “We don't typically expect the nodules to disappear completely, but they may soften or shrink.”

In this case, the patient noticed the nodules had shrunk to roughly half their original size within several weeks after completing treatment. His discomfort and flexibility have improved considerably.

before and after radiation therapy

Now one year after radiation therapy, the patient continues to be able to perform daily activities, and hasn’t needed any additional intervention. “It’s very gratifying to see him be able to continue to enjoy guitar and other activities he’s passionate about,” says Dr. Tendulkar.

Advertisement

Key takeaways

Based on this case and similar experiences, Dr. Tendulkar shared key points:

It's very helpful to have a multidisciplinary evaluation and assessment of the condition, which is typically diagnosed by a primary care provider or hand surgeon.

“There's not a lot of public knowledge about Dupuytren's disease. It does require a bit of advocacy on the part of physicians and patients who have this condition to raise awareness that these nodules can develop into permanent disabling contractures if left untreated, and that radiation is one potential option to delay or prevent the progression into a contracture,” says Dr. Tendulkar.

The dosage for a benign condition like this is roughly half the amount that someone would receive for treating cancer. “In general, there are some risks associated with radiation therapy, including the possibility of secondary cancer, but I’m not aware of any cancers of the hand that have been reported as a direct result of this type of radiation therapy,” Dr. Tendulkar says.

If you’ve been diagnosed with Dupuytren’s nodules at the early stage, you may want to talk with a radiation oncologist to see if they have experience treating this condition, which can be quite bothersome and may affect quality of life.

Advertisement

Related Articles

Dr. Tendulkar
Radiation Therapy Effective for Treating Benign Proliferative Disease of the Extremities

Noninvasive treatment may slow progression of Dupuytren's disease and plantar fibromatrosis

22-ORI-3183860 CQD 650×450
November 1, 2023/Orthopaedics/Upper Extremity
Pollicization or Reconstruction? Managing Congenital Thumb Hypoplasia

Latest concepts in the surgical creation of functional, opposable thumbs in early childhood

Dr. Ali and patient
January 29, 2026/Cancer/News & Insight
Real-World Data Reveals Gap Between Guidelines and Practice in HER2+ Breast Cancer Care

Standard of care is linked to better outcomes, but disease recurrence and other risk factors often drive alternative approaches

Dr. Thomas Budd
January 28, 2026/Cancer/Innovations
Breast Cancer Vaccine Moves One Step Forward

Phase 1 study demonstrates immune response in three quarters of patients with triple-negative breast cancer

Dr. Mukhejee and colleagues
January 22, 2026/Cancer/News & Insight
Rare Cancers and Blood Disease Program Accelerates Diagnostic Journey

Multidisciplinary teams bring pathological and clinical expertise

genetic test
January 16, 2026/Cancer/News & Insight
Five Percent of U.S. Population Carries Pathogenic Variants Associated with Cancer Risk

Genetic variants exist irrespective of family history or other contributing factors

GLP-1
January 12, 2026/Cancer/Blood Cancers
GLP-1a Therapy Improves Survival in Patients with Polycythemia Vera and Myelodysplastic Syndromes

Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists

Oncology nurse
January 9, 2026/Cancer
Improving Patient Experience in Inpatient Hematology: A Nursing Perspective

Structured interventions enhance sleep, safety and caregiver resiliency in high-acuity units

Ad